National HealthCare Corporation (NYSEAMERICAN:NHC - Get Free Report) Director David Gifford sold 1,779 shares of the company's stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $225.42, for a total transaction of $401,022.18. Following the sale, the director directly owned 1,030 shares of the company's stock, valued at approximately $232,182.60. This represents a 63.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
National HealthCare Price Performance
Shares of NYSEAMERICAN:NHC traded up $0.44 during trading on Friday, hitting $222.70. 147,492 shares of the company's stock were exchanged, compared to its average volume of 111,936. National HealthCare Corporation has a 52-week low of $111.24 and a 52-week high of $239.29. The business's 50-day simple moving average is $218.93 and its 200 day simple moving average is $189.65. The company has a market cap of $3.49 billion, a price-to-earnings ratio of 25.05 and a beta of 0.61.
National HealthCare (NYSEAMERICAN:NHC - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $1.74 EPS for the quarter. The company had revenue of $408.03 million during the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%.
National HealthCare Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.67 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $2.68 dividend on an annualized basis and a yield of 1.2%. National HealthCare's dividend payout ratio (DPR) is 61.89%.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the stock. The Goldman Sachs Group raised shares of National HealthCare to a "strong-buy" rating in a research note on Monday, May 18th. BMO Capital Markets upgraded National HealthCare to a "hold" rating in a research report on Monday, May 18th. Robert W. Baird raised National HealthCare to a "strong-buy" rating in a research report on Monday, May 18th. Finally, Royal Bank Of Canada raised shares of National HealthCare to a "hold" rating in a research note on Monday, May 18th. Two investment analysts have rated the stock with a Strong Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Buy".
View Our Latest Stock Report on National HealthCare
Hedge Funds Weigh In On National HealthCare
A number of institutional investors and hedge funds have recently made changes to their positions in NHC. Mariner LLC raised its position in shares of National HealthCare by 0.9% during the 4th quarter. Mariner LLC now owns 6,839 shares of the company's stock worth $938,000 after purchasing an additional 59 shares during the last quarter. EverSource Wealth Advisors LLC boosted its holdings in shares of National HealthCare by 28.5% in the 1st quarter. EverSource Wealth Advisors LLC now owns 311 shares of the company's stock valued at $50,000 after purchasing an additional 69 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of National HealthCare by 1.2% during the 1st quarter. The Manufacturers Life Insurance Company now owns 6,048 shares of the company's stock valued at $966,000 after buying an additional 70 shares during the period. ProShare Advisors LLC increased its holdings in shares of National HealthCare by 3.3% during the 4th quarter. ProShare Advisors LLC now owns 2,466 shares of the company's stock worth $338,000 after buying an additional 78 shares during the last quarter. Finally, Hsbc Holdings PLC raised its position in shares of National HealthCare by 1.2% in the 1st quarter. Hsbc Holdings PLC now owns 7,969 shares of the company's stock worth $1,275,000 after buying an additional 93 shares during the period. 56.44% of the stock is owned by institutional investors and hedge funds.
About National HealthCare
(
Get Free Report)
National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.
Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider National HealthCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National HealthCare wasn't on the list.
While National HealthCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.